US frustration with pharmaceutical policy in Australia has grown in recent years, not just in relation to pricing but intellectual property and even biosimilars. …
New Stories
-
Minister confirms interest in agreement with wholesalers
September 22, 2017 - Latest News -
Pfizer sues J&J over 'biosimilar exclusion' contracts
September 22, 2017 - Latest News -
Ferris: Australia falling behind
September 22, 2017 - Latest News -
Consumers unhappy over codeine
September 22, 2017 - Latest News -
European approval for new PD-L1 antibody
September 22, 2017 - Latest News -
Cholesterol biologics show benefit for diabetics
September 21, 2017 - Latest News -
Massive saving but not very feasible?
September 21, 2017 - Latest News